Efficacy [qlco]    
Safeties [hcpp]    
Combination [qlco]    
With [qlco]    
Mammalian Target of Rapamycin Inhibitors [moft]    
Recurrent Hepatocellular Carcinoma [neop]    
Liver Transplant [topp]    
Currently [tmco]    
Consensus [socb]    
Most [qnco]    
treatment [ftcn]    
Recurrence [phpr]    
Hepatocellular carcinoma [neop]    
Liver Transplant [topp]    
This [euka]    
Open [spco]    
retrospective [resa]    
Uncontrolled Study [resa]    
Cohort [popg]    
Design [acty]    
To [qlco]    
Evaluable [ftcn]    
Safeties [hcpp]    
Preliminary [tmco]    
Efficacy [qlco]    
Combination [qlco]    
use [ftcn]    
Of [spco]    
Mammalian [mamm]    
Target [ftcn]    
Inhibitor [qlco]    
Set [ftcn]    
31 [inpr]    
patient [podg]    
suffer [mobd]    
Hepatocellular carcinoma [neop]    
Recurrence [phpr]    
Liver Transplant [topp]    
immunosuppressive therapies [topp]    
Change [ftcn]    
To [qlco]    
Mammalian Target of Rapamycin Inhibitors [moft]    
System [ftcn]    
treatment [ftcn]    
Initial [idcn]    
This [euka]    
Combination [qlco]    
Maintain [ftcn]    
Symptomatic [ftcn]    
Tumor Progression [neop]    
Death [orgf]    
Hepatic [blor]    
Decompensated [fndg]    
Unacceptable [qlco]    
toxic [qlco]    
Occur [acty]    
primary treatment [topp]    
Efficacy [qlco]    
Overall [inpr]    
Survival [acty]    
Progression-Free Survival [qnco]    
secondary [neop]    
Efficacy [qlco]    
Overall Response [fndg]    
Rate [acty]    
toxic [qlco]    
Parameter [fndg]    
Associated [qlco]    
use [ftcn]    
Mammalian Target of Rapamycin Inhibitors [moft]    
Analyzed [resa]    
Overall Response [fndg]    
Rate [acty]    
Response [orga]    
evaluation criteria [inpr]    
solid tumor [neop]    
<3 [qnco]    
1+ [qnco]    
sustain [ftcn]    
Stabilisation [topp]    
Disease [dsyn]    
Addition [ftcn]    
Case [ftcn]    
median [spco]    
Overall [inpr]    
Survival [acty]    
month [tmco]    
Confidence Interval [qnco]    
month [tmco]    
median [spco]    
Time [tmco]    
progress [patf]    
month [tmco]    
Confidence Interval [qnco]    
2 Months [tmco]    
Only [qnco]    
Grade 4 [qlco]    
Case [ftcn]    
Hyperglycaemia [dsyn]    
1+ [qnco]    
Case [ftcn]    
Grade 4 [qlco]    
Mucosal [patf]    
Report [inpr]    
Possibly [qlco]    
Relate [orch]    
To [qlco]    
Mammalian Target of Rapamycin Inhibitors [moft]    
Most [qnco]    
Common [qnco]    
Severe Adverse Event [fndg]    
Probably [idcn]    
Relate [orch]    
Diarrhea [sosy]    
Conclusion [idcn]    
Inhibitor [qlco]    
Effect [qlco]    
toxic [qlco]    
patient [podg]    
Transplant [topp]    
Hepatocellular carcinoma [neop]    
Recurrence [phpr]    
Not [ftcn]    
Radical [chvs]    
Therapies [ftcn]    
toxic [qlco]    
Efficacy [qlco]    
Need [qlco]    
To [qlco]    
Further [spco]    
Evaluable [ftcn]    
RANDOM [resa]    
Controlled Study [resa]    
Combination [qlco]    
consider [idcn]    
Valid [qlco]    
Option [ftcn]    
Liver [bpoc]    
[c] [qnco]    
